Intrexon Corporation
Intrexon Corporation is developing DNA control systems to enhance the safety and efficacy of existing and novel biological therapeutics. The company's technology employs special genetic components and activator compounds to tightly control the delivery, targeting, activation, regulation and location of biologics. The goal of such DNA-mediated control is to improve the safety of those biologics while extending their clinical effectiveness. The company is currently engaged in clinical and pre-clinical studies related to solid tumor cancers and other intractable diseases that must be addressed with powerful biotherapeutic strategies. Together with its partners, Intrexon is committed to improving safety and clinical outcomes through the use of controllable biotherapeutics. For more information, please visit www.dna.com.
Synchrony, Inc.
Synchrony is a producer of magnetic bearings, power conversion, and control systems for large, industrialized customers. The company is dedicated to providing world-class products and services that improve the performance and environmental friendliness of rotating machinery through its proprietary magnetic levitation and power conversion technologies. Founded in 1993, Synchrony has received eight Small Business Innovation Research Awards from NASA and the Department of Defense. For more information, please visit www.synchrony.com.
LevelVision
LevelVision is a digital out-of-home media company specializing in innovative video programming over unique consumer intercepts in place-based markets. LevelVision not only offers the digital devices, but also the network operations that deliver the content. The content is designed and refreshed with an eye toward audience experience to optimize effectiveness, as performed by a dedicated editorial and operational staff expert in the venue genre. The result is a complete solution for enhanced engagement, seamlessly integrated, optimized and supported. Through LevelVision™: College we have deployed our innovative and patented floor-based screens in more than 315 college bookstores in 234 cities across 44 states and are delivering over 20 million audience experiences to the highly valuable 18-24 year old consumer market. For more information, please visit www.levelvision.com.
Pinnacle Pharmaceuticals
Pinnacle Pharmaceuticals, Inc. is a specialty pharmaceutical company dedicated to the development of novel therapies in areas of significant unmet medical need. Pinnacle develops critical-care therapeutics for antibacterial, oncology, and pain management indications by leveraging its supramolecular chemistry platform and drug formulation expertise. Additionally, Pinnacle is advancing novel and potent synergistic compounds for current antibiotic regimes to treat patients suffering from infections refractory to the current gold-standard. Pinnacle is pursuing therapeutics for several infectious disease indications including methicillin resistant Staphylococcus aureus (MRSA) and vancomycin resistant enterococci (VRE). Pinnacle is rapidly progressing its lead compounds from the research laboratory into clinical development. For more information, please visit www.pinnaclepharmaceuticals.com
Keraderm
Keraderm Corp., headquartered in Blacksburg Virginia, is an early stage medical device company that has developed a patented, innovative, and effective treatment for nail infections. The treatment eliminates the potential serious side effects of current medications and has shown encouraging results in preclinical and early clinical testing. The Company believes that the ability to safely and effectively treat nail infections, the low cost, and the shortened treatment time of the Keraderm light-based solution will rapidly transform this billion-dollar-plus market. For more information, visit www.keraderm.com